
- /
- Supported exchanges
- / US
- / ANPCY.OTCQX
Angle PLC ADR (ANPCY OTCQX) stock market data APIs
Angle PLC ADR Financial Data Overview
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated analysis. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with high analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal transition; and CellKeep Slide, a CTC harvesting technology. In addition, the company offers laboratory services, including enumeration of epithelial and mesenchymal CTC populations; Portrait Flex, an immunofluorescence assay for the identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition; DNA damage response; Portrait PD-L1, evaluates CTCs; and custom CTC assays. ANGLE plc has a strategic partnership with Bio View Ltd to develop a human epidermal growth factor receptor 2 assay kit for breast cancer; and agreement with NuProbe USA, Inc. to use its proprietary pan-cancer next generation sequencing (NGS) panel. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Angle PLC ADR data using free add-ons & libraries
Get Angle PLC ADR Fundamental Data
Angle PLC ADR Fundamental data includes:
- Net Revenue: 2 024 K
- EBITDA: -16 324 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Angle PLC ADR News

Angle PLC Announces Result of 2023 Annual General Meeting
GUILDFORD, SURREY / ACCESSWIRE / June 28, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today...


Angle PLC Announces Standard Form for Notification of Major Holdings
GUILDFORD, SURREY / ACCESSWIRE / June 27, 2023 / TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0034330679 Issuer Name ANGLE plc UK or Non-UK Issuer UK 2. Reas...

ANGLE Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag
ANGLE (LON:AGL) Full Year 2022 Results Key Financial Results Net loss: UK£21.7m (loss widened by 45% from FY 2021). UK£0.088 loss per share (further deteriorated from UK£0.067 loss in FY 2021). e...

ANGLE Announces Senior Management Appointments
Brett Swansiger joins as Chief Commercial Officer Karen Miller PhD joins as Chief Scientific Officer GUILDFORD, SURREY / ACCESSWIRE / June 5, 2023 / ANGLE plc ("the Company") (AIM:AGL)(OTCQX:ANPCY),...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.